Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

837
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
837
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

930
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
930
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

3.6K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.6K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

3.2K
The pathophysiology of pneumonia involves the following steps:
3.2K
Mechanical Ventilation II: Invasive Ventilation01:23

Mechanical Ventilation II: Invasive Ventilation

808
Ventilators are essential medical equipment used to aid patients with respiratory difficulties. Their primary function is to assist or replace spontaneous breathing by providing mechanical ventilation. There are two general classes of mechanical ventilators: negative-pressure and positive-pressure ventilators.
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
808
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

939
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
939

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Delayed intubation and 60-day mortality in severe COVID-19-associated acute respiratory failure in an emulated target trial using the OUTCOMEREA network.

Scientific reports·2026
Same author

Clinical significance of negative BioFire® pneumonia panel in ICU: Diagnosis, management, and outcomes.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same author

Fosfomycin Use in Treating Severe Difficult-to-Treat Gram-Negative Infections-A Comprehensive Review.

Antibiotics (Basel, Switzerland)·2026
Same author

The time has come for optimizing beta-lactam therapy in critically ill patients with renal dysfunction.

Intensive care medicine·2026
Same author

Restrictive vs Liberal Physical Restraint Strategies in Critically Ill Patients: The R2D2-ICU Randomized Clinical Trial.

JAMA·2026
Same author

Correction: Serum NSE and EEG sleep figures for prognostication of short-term outcomes in adults with severe COVID-19 pneumonia: a prospective single-center study.

Scientific reports·2026
Same journal

Exploring potential strategies to enhance memory and cognition in aging mice.

F1000Research·2026
Same journal

Construction an Implicit Block Multi-Steps Approach for Solving Sixth-Order Fractional Differential Equations.

F1000Research·2026
Same journal

Kansei Engineering in the Evolving Service Sector: A Decade of Insights.

F1000Research·2026
Same journal

A Safety-First Mindset:  Role of Patient Safety Culture in Enhancing Healthcare Workers' Emotional Intelligence.

F1000Research·2026
Same journal

Decoding Decisions: Personality-Interest Motivational Sequences as Predictors of Career Paths.

F1000Research·2026
Same journal

Beyond the Transparent Barrier: A Domain Visualization and Integrative Review of Contemporary Research on Gender-Based Professional Stasis.

F1000Research·2026
See all related articles

Related Experiment Video

Updated: Feb 17, 2026

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

12.5K

Update on ventilator-associated pneumonia.

Jean-Francois Timsit1,2, Wafa Esaied1, Mathilde Neuville2

  • 1IAME, Inserm U1137, Paris Diderot University, Paris, F75018, France.

F1000Research
|December 12, 2017
PubMed
Summary
This summary is machine-generated.

Ventilator-associated pneumonia (VAP) diagnosis is challenging due to unreliable signs. Infection-related ventilator-associated complications offer a quality benchmark, guiding appropriate antimicrobial use and improving patient outcomes.

Keywords:
VAPantimicrobialsnosocomial infectionventilator-associated pneumonia

More Related Videos

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

3.2K
An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient
07:16

An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient

Published on: November 30, 2022

4.9K

Related Experiment Videos

Last Updated: Feb 17, 2026

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

12.5K
Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

3.2K
An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient
07:16

An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient

Published on: November 30, 2022

4.9K

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Pulmonology

Background:

  • Ventilator-associated pneumonia (VAP) is a common, severe hospital-acquired infection in ICUs.
  • Diagnosing VAP is difficult due to ambiguous clinical and radiological findings.
  • Infection-related ventilator-associated complications (IVAC) are proposed as a quality indicator.

Purpose of the Study:

  • To review diagnostic challenges and management strategies for VAP.
  • To highlight the role of IVAC as a quality benchmark.
  • To emphasize appropriate antimicrobial use in VAP management.

Main Methods:

  • Literature review of VAP diagnosis, prevention, and treatment.
  • Discussion of current diagnostic criteria and proposed alternatives (IVAC).
  • Analysis of antimicrobial selection, dosing, and duration for VAP.

Main Results:

  • Clinical and radiological signs for VAP are often inaccurate.
  • Prevention bundles effectively reduce VAP rates.
  • Quantitative cultures and targeted antimicrobials improve outcomes and limit resistance.

Conclusions:

  • Accurate VAP diagnosis is crucial for appropriate antimicrobial therapy.
  • IVAC serves as a valuable surrogate for VAP quality assessment.
  • Optimized antimicrobial strategies, including appropriate dosing and duration, are essential for critically ill patients.